West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2023 Results Conference Call April 27, 2023 9:00 AM ET Company Participants Quintin Lai - IR Eric Green - CEO Bernard Birkett - CFO Conference Call Participants Larry Solow - CJS Securities Paul Knight - KeyBanc Capital Markets Matt Larew - William Blair Jacob Johnson - Stephens Derik De Bruin - Bank of America John Sourbeer - UBS Quintin Lai [Call Starts Abruptly] …conference call. We issued our financial results this morning, and the release has been posted ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 530 Herman O. West Drive, Exton, PA 19341-0645 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: 610-594-2900 Securities re ...

| --- | --- | --- | |---------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | West Pharmaceutical Services, Inc. | | | | Eric M. Green | | | | President, CEO and Chair of the Board | | | March 2023 Investor Conferences Safe Harbor Statement Cautionary Statement Under the Private Securities Litigation Reform Act of 1995 This presentation and any accompanying management commentary contain "forwardlooking statements" as that term is defined in the Private Securities Litigation ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-8036 WEST PHARMACEUTICAL SERVICES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 23-1210010 (State or other ...

West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2022 Earnings Conference Call February 16, 2023 9:00 AM ET Company Participants Quintin Lai - VP, Strategy & IR Eric Green - Chair, President & CEO Bernard Birkett - SVP and Chief Financial & Operations Officer Conference Call Participants Lawrence Solow - CJS Securities Matthew Larew - William Blair & Company Jacob Johnson - Stephens Inc. John Sourbeer - UBS Derik De Bruin - Bank of America Merrill Lynch Paul Knight - KeyBanc Capital Markets David Windley - ...

Fourth-Quarter 2022 and Full Year Results WST Q4/FY 2022 Earnings 1 Fourth Quarter Overall Net Sales $708.7M | 3.0% Diluted Earnings Per Share: $1.36 Adjusted Diluted Earnings Per Share: $1.77 "I am pleased to report that we had a solid finish to 2022 and that we enter 2023 with a strong order book and continued demand for our core business. I am extremely proud of the many accomplishments by our global team members, as our Company has supplied critical components, solutions and systems to our base and COVI ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Pennsylvania 23-1210010 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) (Mark One) 530 Herman O. West Drive, Exton, PA 19341-0645 ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Address of principal executive offices) (Zip Code) For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d ...

Third-Quarter 2022 WST Q3 2022 Earnings 1 Third Quarter Overall Net Sales $686.9M | 2.8% Diluted Earnings Per Share: $1.59 Adjusted Diluted Earnings Per Share: $2.03 "While our base, non-COVID-19 demand continues to grow, we have had multiple constraints that impacted our financial results. Delays in expansion projects as well as customer delivery timing and mix-shift related productivity impacts resulted in lower-than-expected overall high-value product (HVP) net sales. We expect to resolve these issues in ...

West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2022 Earnings Conference Call October 27, 2022 9:00 AM ET Company Participants Quintin Lai – Vice President-Investor Relations Eric Green – Chief Executive Officer Bernard Birkett – Chief Financial Officer Conference Call Participants Paul Knight – KeyBanc Larry Solow – CJS Securities Derik DeBruin – Bank of America Dave Windley – Jefferies Jacob Johnson – Stephens Operator Good day and thank you for standing by. Welcome to the Q3 2022 West Pharmaceutical Ser ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-8036 WEST PHARMACEUTICAL SERVICES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 23-1210010 (State or ot ...